Table 2 Number and percentage of participants having each health condition at baseline, 12-month, and 24-month follow-ups
|  | Baseline (N = 1472) | 12-month follow-up (N = 1130) | 24-month follow-up (N = 806) |
|---|---|---|---|
Health conditions | Â | ||
| Â | Yes, N (%) | ||
Myocardial infarction (history of heart attacks) | 130 (8.8) | 128 (11.3) | 96 (11.9) |
Congestive heart failure | 67 (4.6) | 68 (6.0) | 53 (6.6) |
Hypertension/high blood pressure | 566 (38.5) | 509 (45.0) | 390 (48.4) |
Diagnosed depression | 221 (15.0) | 212 (18.8) | 187 (23.2) |
Peripheral vascular disease | 152 (10.3) | 183 (16.2) | 157 (19.5) |
Aortic aneurysm | 19 (1.3) | 20 (1.77) | 18 (2.2) |
Poor circulation | 93 (6.3) | 116 (20.3) | 107 (13.3) |
Cerebrovascular disease | 228 (15.5) | 216 (19.1) | 166 (20.6) |
Stroke | 110 (7.5) | 105 (9.3) | 79 (9.8) |
Cerebrovascular accident | 7 (0.5) | 7 (0.6) | 4 (0.5) |
Transient Ischemic attack | 108 (7.3) | 124 (11.0) | 104 (12.9) |
Chronic bad chest | 200 (13.6) | 181 (16.0) | 134 (16.6) |
Asthma | 103 (7.0) | 99 (8.8) | 74 (9.2) |
Chronic obstructive pulmonary disease | 53 (3.6) | 54 (4.8) | 38 (4.7) |
Chronic bronchitis | 19 (1.3) | 20 (1.8) | 19 (2.4) |
Emphysema | 14 (1.0) | 19 (1.7) | 16 (2.0) |
Inflammation affecting the joints | 434 (29.5) | 416 (36.8) | 340 (42.2) |
Lupus | 2 (0.1) | 2 (0.2) | 0 (0) |
Rheumatoid arthritis | 205 (13.9) | 233 (20.6) | 212 (26.3) |
Connective tissue disease | 10 (0.7) | 10 (0.9) | 5 (0.6) |
Vasculitis | 8 (0.5) | 11 (1.0) | 8 (1.0) |
Peptic/stomach ulcer disease | 59 (4.01) | 54 (0.4) | 42 (5.2) |
Skin ulcer | 24 (1.6) | 35 (3.1) | 31 (3.8) |
Bed sores | 4 (0.3) | 6 (0.5) | 3 (0.4) |
Repeated cellulitis | 8 (0.5) | 13 (1.2) | 13 (1.6) |
Diabetes controlled with insulin or equivalent | 189 (12.8) | 171 (15.1) | 132 (16.4) |
Diabetes with end organ damage | 29 (2.0) | 23 (2.0) | 29 (3.6) |
Damage to the retina | 12 (0.8) | 13 (1.2) | 11 (1.4) |
Nerve damage | 6 (0.4) | 10 (0.9) | 12 (1.5) |
Kidney damage | 9 (0.6) | 7 (0.6) | 9 (1.1) |
Brittle diabetes | 2 (0.1) | 2 (0.2) | 2 (0.2) |
Moderate or severe chronic kidney disease | 38 (2.6) | 39 (3.5) | 34 (3.0) |
Hemiplegia | 3 (0.2) | 5 (0.4) | 4 (0.5) |
Cancer within the last five years | 134 (9.1) | 134 (11.9) | 115 (14.3) |
Breast cancer | 28 (1.9) | 24 (2.1) | 18 (2.2) |
Colon cancer | 11 (0.7) | 16 (1.4) | 15 (1.9) |
Prostate cancer | 45 (3.1) | 44 (3.9) | 29 (3.6) |
Lung cancer | 4 (0.3) | 3 (0.3) | 4 (0.5) |
Skin cancer | 19 (1.3) | 20 (1.8) | 23 (2.9) |
Blood cancer/lymphoma | 4 (0.3) | 5 (0.4) | 6 (0.7) |
Acute or chronic leukemia | 0 (0) | 1 (0.1) | 2 (0.2) |
Cancer within the past five years that has metastasized | 7 (0.5) | 12 (1.1) | 12 (1.5) |
Mild liver disease | 5 (0.3) | 7 (0.6) | 5 (0.6) |
Hepatitis B | 0 (0) | 5 (0.4) | 0 (0) |
Hepatitis C | 0 (0) | 0 (0) | 0 (0) |
Cirrhosis | 2 (0.1) | 2 (0.2) | 1 (0.1) |
Liver disease (moderate to severe) | 1 (0.1) | 3 (0.3) | 0 (0) |
Chronic jaundice | 1 (0.1) | 1 (0.1) | 0 (0) |
Liver failure | 1 (0.1) | 2 (0.2) | 0 (0) |
Liver transplant | 0 (0) | 0 (0) | 0 (0) |
AIDS or HIV | 0 (0) | 0 (0) | 0 (0) |
Taking warfarin | 154 (10.5) | 115 (10.2) | 74 (9.2) |